Anavex Life Sciences Corp (AVXL)

[Hoskuld]

2-73 works: it reduces the rate of brain shrink, it has a dramatic effect on tau and beta amyloid, and it results in significant slowing of cognitive decline. It has no SAEs. It has a positive effect on ADL and people on the drug fell at 50% of the rate of the elderly people who were not on the drug. The spin that sometimes occurs here is worthless: the EMA will decide and then the FDA will decide. They aren't going to read what investor2014, or doc####, or day traders chatting up their current positions write. IMO this is a very high percentage play - for AD, for PD, and more. It is frustrating to see how slowly Anavex moves, but in the end it should be worth it and then some.